Apotex Suffers Defeat In Acular Dispute
Law360 (September 11, 2007, 12:00 AM EDT) -- In a major setback for Apotex Inc., a federal judge has found that the Canadian drug maker’s application for a generic version of anti-inflammatory eye treatment Acular infringed a patent held...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
